← Back to All Filings

Penumbra Director Sells $4.6M in Stock via 10b5-1 Plan

Low SignificanceDecember 15, 2025 at 7:32:28 PM EST

Penumbra Inc

$PEN4CIK: 0001321732

Subscribe to track PEN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Penumbra Director Sells $4.6M in Stock via 10b5-1 Plan

Company: Penumbra Inc (PEN) Form: 4 | Filed: 2025-12-15 Significance: Low

Insider: Bose Arani Title: null | Relationship: Director

Transaction: • Type: Sell • Shares: 15,000 • Avg. Price: $308.84 • Value: $4,632,569 • Owned After: 259,020

Key Insight: A director conducted a series of pre-planned sales under a Rule 10b5-1 plan. The total value is minor relative to Penumbra's $10.97B market cap (0.042%).

Market Context: These sales are automated and not necessarily indicative of a change in the insider's outlook on the company. The sale represents a small portion (~5.5%) of the director's total holdings.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Penumbra Inc (PEN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director sold $4.6 million worth of stock in a series of pre-planned transactions under a Rule 10b5-1 trading plan.
  • Market Impact: The transaction is not material, representing a negligible fraction of the company's market capitalization and public float. It is unlikely to influence market sentiment.

Company Information

FieldValue
CompanyPenumbra Inc
Ticker SymbolPEN
CIK0001321732
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameBose Arani
CIK0001651318
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-11
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved15,000
Price Per Share$308.84 (Weighted Average)
Total Value$4,632,569.11
Shares Owned After259,020 (258,462 Indirectly, 558 Directly)
Ownership TypeIndirect (By LLC)

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,632,569
% of Market Cap0.042%
Shares Transacted15,000
% of Shares Outstanding0.038%
Post-Transaction Ownership259,020 shares (0.66% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a $10.97 billion market capitalization, a $4.6 million transaction is considered routine and immaterial.
  • Ownership Concentration: The insider remains a significant shareholder with 259,020 shares, representing 0.66% of the company's outstanding shares. The sale of 15,000 shares constitutes approximately 5.5% of the insider's prior holdings, which is not a substantial divestment.
  • Dilution Impact: Not applicable as this is a secondary market sale, not an issuance of new shares.
  • Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding, placing it firmly in the 'Low' significance category.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale was executed under a pre-disclosed Rule 10b5-1 trading plan. Such plans are established in advance to automatically execute trades, typically for diversification or personal financial management, and are not considered a reflection of new, non-public information about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is too small relative to the company's average trading volume and public float to have a noticeable impact.
  • Sentiment Indicator: Neutral. The pre-planned nature of the sale negates any potential negative sentiment that might arise from an unplanned insider disposition.

Additional Context

Transaction Notes

  • Special Circumstances: As noted in Footnote F1 of the filing, all sales were effected pursuant to a Rule 10b5-1 trading plan. The shares sold were held indirectly by Bose Family Holdings II, LLC.
Topics:#SECFiling#InsiderTrading#PEN#Penumbra#Form4#InsiderSell#StockMarket#Investing#Healthcare#MedTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.